Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2016-07-13 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VITRY-SUR-SEINE (94400), Val-de-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE ABISROR : revenue, balance sheet and financial ratios
PHARMACIE ABISROR is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VITRY-SUR-SEINE (94400),
this company of category PME
shows in 2025 a net income positive of 20 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ABISROR (SIREN 821305760)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
19 932 €
72 722 €
-12 931 €
173 708 €
320 512 €
38 548 €
89 043 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE ABISROR generates positive net income of 20 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 89 k€ -> 20 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
19 932 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 461%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 16%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
460.788%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
16.052%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
-2176.856
-3340.472
1271.67
648.855
609.926
486.823
460.788
Financial autonomy
-4.275
-2.684
6.424
12.11
12.643
15.506
16.052
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
460.792025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Watch
In 2025, the debt ratio of PHARMACIE ABISROR (460.79) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
16.05%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Watch
In 2025, the financial autonomy of PHARMACIE ABISROR (16.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 185.58. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
185.581
Liquidity indicators evolution PHARMACIE ABISROR
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
125.253
197.911
238.025
264.179
201.171
200.007
185.581
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
185.582025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Good
In 2025, the liquidity ratio of PHARMACIE ABISROR (185.58) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE ABISROR in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE ABISROR is estimated at
316 622 €
(range 214 861€ - 496 823€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
214k€316k€496k€
316 622 €Range: 214 861€ - 496 823€
NAF 5 année 2025
Valuation method used
Net Income Multiple
19 932 €
×
15.9x
=316 622 €
Range: 214 861€ - 496 824€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ABISROR with other companies in the same sector:
Frequently asked questions about PHARMACIE ABISROR
What is the revenue of PHARMACIE ABISROR ?
The revenue of PHARMACIE ABISROR is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE ABISROR profitable?
Yes, PHARMACIE ABISROR generated a net profit of 20 k€ in 2025.
Where is the headquarters of PHARMACIE ABISROR ?
The headquarters of PHARMACIE ABISROR is located in VITRY-SUR-SEINE (94400), in the department Val-de-Marne.
Where to find the tax return of PHARMACIE ABISROR ?
The tax return of PHARMACIE ABISROR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ABISROR operate?
PHARMACIE ABISROR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart